Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Enza Vernucci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9354-6728; OpenAlex author ID A5034300510. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 4 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 10

  1. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  2. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗
  3. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.04.017↗
  4. Metabolic Alterations in Pancreatic Cancer Progression. Co-author DOI 10.3390/cancers12010002↗
  5. Evaluating the Metabolic Impact of Hypoxia on Pancreatic Cancer Cells. First author DOI 10.1007/978-1-4939-7665-2_8↗
  6. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2017.04.029↗
  7. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2017.06.004↗
  8. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-3062↗
  9. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-1151↗
  10. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Co-author DOI 10.18632/oncotarget.5843↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pankaj Kumar Singh · 10 shared papers, 2015–2022 · strength 0.78
  2. Surendra Kumar Shukla · 9 shared papers, 2015–2022 · strength 0.67
  3. Ryan J. King · 8 shared papers, 2015–2022 · strength 0.59
  4. Jaime Abrego · 7 shared papers, 2017–2022 · strength 0.54
  5. Aneesha Dasgupta · 7 shared papers, 2015–2022 · strength 0.52
  6. Nina V. Chaika · 7 shared papers, 2015–2022 · strength 0.50
  7. Venugopal Gunda · 7 shared papers, 2015–2022 · strength 0.48
  8. Divya Murthy · 5 shared papers, 2017–2022 · strength 0.43
  9. Kuldeep Singh Attri · 4 shared papers, 2017–2022 · strength 0.36
  10. Kamiya Mehla · 4 shared papers, 2015–2021 · strength 0.28
  11. Michael Anthony Hollingsworth · 3 shared papers, 2017–2022 · strength 0.27
  12. Paul M. Grandgenett · 3 shared papers, 2017–2022 · strength 0.27
  13. Chunbo He · 2 shared papers, 2021–2022 · strength 0.21
  14. Scott E. Mulder · 2 shared papers, 2021–2022 · strength 0.21
  15. Ravi Kumar Thakur · 2 shared papers, 2021–2022 · strength 0.21
  16. Spas Dimitrov Markov · 1 shared paper, 2020 · strength 0.11
  17. Jean L. Grem · 2 shared papers, 2017 · strength 0.10
  18. Lyudmyla Derby Berim · 2 shared papers, 2017 · strength 0.10
  19. Joshua J. Souchek · 2 shared papers, 2015–2017 · strength 0.10
  20. Nicholas James Mullen · 1 shared paper, 2021 · strength 0.09
  21. Tuo Hu · 1 shared paper, 2021 · strength 0.09
  22. Xiao Fu · 1 shared paper, 2021 · strength 0.09
  23. David Arthur Tuveson · 1 shared paper, 2021 · strength 0.09
  24. Vikrant Rai · 1 shared paper, 2019 · strength 0.08
  25. Saber Tadros · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.